Hereditary Hemochromatosis

USMLE Step 1 trap: Uses ferritin rather than transferrin saturation as the primary screening test for hemochromatosis. Transferrin saturation > 45% is the best initial screening test; ferritin is elevated but is a nonspecific acute-phase reactant.

Hereditary hemochromatosis is an autosomal recessive disorder of iron regulation, most commonly caused by the C282Y mutation in the HFE gene. The result is unregulated iron absorption and progressive deposition in parenchymal organs — liver, pancreas, heart, joints, pituitary, and skin. USMLE Step 1 tests this at multiple levels: pure recall (HFE, C282Y, autosomal recessive), clinical application (recognizing the 'bronze diabetes' constellation), and mechanism (why the mutation causes overload in the first place). The mechanism angle is where students consistently lose points.

The exam loves to present a middle-aged Northern European man with cirrhosis, diabetes, arthralgias, skin hyperpigmentation, and hypogonadism — and ask you to name the mutation, explain the mechanism, or pick the right first diagnostic test. The tricky part is that all three of those questions have a different answer, and each one has a classic trap. The most common error is reaching for serum ferritin as the screening test — it's elevated, yes, but it's a nonspecific acute-phase reactant. Transferrin saturation above 45% is the correct initial screen.

The mechanism question is the deepest trap. Many students memorize 'HFE mutation → increased iron absorption' without understanding the intermediary step: HFE normally promotes hepcidin expression, and hepcidin blocks ferroportin (the iron exporter on enterocytes and macrophages). Without hepcidin signaling, ferroportin stays open and iron floods in. This is not a transporter defect — it's a regulatory failure. USMLE Step 1 will distinguish these, so the pathway matters.

From real student decks

84%have cards covering this topic

68%have mature cards

Common misconceptions

Common mistake

Wrong: Serum ferritin alone is the best initial screening test for hereditary hemochromatosis.

Right: Transferrin saturation > 45% is the best initial screening test; ferritin is elevated but is a nonspecific acute-phase reactant.

Serum ferritin is elevated in hemochromatosis, but it rises in any inflammatory state, malignancy, or liver disease — making it a poor screening test. Transferrin saturation (serum iron divided by TIBC, times 100) is the right first test because it specifically reflects iron-bound transport capacity and rises early in hemochromatosis before ferritin does. On Step 1, if you see a question asking which test to order first, pick transferrin saturation > 45%, not ferritin.

Common mistake

Wrong: HFE mutation directly causes iron overload by increasing intestinal iron absorption through a transporter defect.

Right: HFE mutation leads to inappropriately low hepcidin production, which fails to inhibit ferroportin, resulting in unregulated intestinal iron absorption.

HFE does not code for an iron transporter — it's a regulator. Normally, HFE protein on hepatocytes senses transferrin saturation and upregulates hepcidin production. Hepcidin then circulates to enterocytes and macrophages and causes ferroportin internalization, blocking iron export into the blood. When HFE is mutated, hepcidin remains inappropriately low, ferroportin stays active, and iron is absorbed unchecked. The defect is regulatory, not structural — a critical distinction for mechanism-based questions.

Common mistake

Gap: Misses why women with hemochromatosis present later than men

Hereditary hemochromatosis presents later in women than men because menstruation delays iron accumulation, so women typically present post-menopausally.

Women have the same genetic mutation as men, but monthly menstrual blood loss acts as a natural form of phlebotomy — it offloads iron continuously throughout reproductive life. This delays the net iron accumulation needed to reach symptomatic thresholds. Once menopause removes that physiologic protection, iron begins to accumulate faster and symptoms emerge, typically one to two decades later than in men. If a vignette describes a postmenopausal woman with the hemochromatosis constellation, don't let the later age or female sex throw you off.

Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →

Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

Know the HFE gene, the C282Y mutation (autosomal recessive inheritance), and the indirect mechanism: HFE mutation → reduced hepcidin → uninhibited ferroportin → excess intestinal iron absorption — not a direct transporter defect.
Recognize the classic multiorgan presentation — cirrhosis, diabetes mellitus, bronze skin, restrictive cardiomyopathy, arthralgias (especially MCP joints), and hypogonadism — and know that it most commonly affects middle-aged Northern European men, with women presenting later due to menstrual iron losses.
Identify transferrin saturation > 45% as the best initial screening test, serum ferritin as a supportive but nonspecific marker, HFE gene testing as confirmatory, and liver biopsy (with Prussian blue stain showing periportal iron) for staging; know that phlebotomy is the treatment.

Can you avoid these mistakes?

A 45-year-old man of Northern European descent presents with fatigue, joint pain in both hands, elevated liver enzymes, and new-onset diabetes. What is the most appropriate initial screening test, and what cutoff makes the result positive?

A patient is found to be homozygous for the HFE C282Y mutation. Explain in two sentences why this leads to iron overload — specifically, which protein's function is lost and what downstream event that protein normally prevents.

A 58-year-old postmenopausal woman is found to have the same C282Y homozygous mutation as her 44-year-old brother, who already has cirrhosis. Why is she presenting with symptoms later than her brother despite identical genetics?

A liver biopsy is performed on a patient with confirmed hereditary hemochromatosis. What stain is used to visualize iron deposition, what pattern of deposition is expected, and what is the first-line long-term treatment?

Hereditary Hemochromatosis

Common misconceptions

What the exam tests

Can you avoid these mistakes?

Related topics